Ehlken B - Search Results

1

Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.

Lordick F, Ehlken B, Ihbe-Heffinger A, Berger K, Krobot KJ, Pellissier J, Davies G, Deuson R. Lordick F, et al. Among authors: ehlken b. Eur J Cancer. 2007 Jan;43(2):299-307. doi: 10.1016/j.ejca.2006.09.019. Epub 2006 Nov 28. Eur J Cancer. 2007. PMID: 17134890

2

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.

Ihbe-Heffinger A, Ehlken B, Bernard R, Berger K, Peschel C, Eichler HG, Deuson R, Thödtmann J, Lordick F. Ihbe-Heffinger A, et al. Among authors: ehlken b. Ann Oncol. 2004 Mar;15(3):526-36. doi: 10.1093/annonc/mdh110. Ann Oncol. 2004. PMID: 14998860 Free article.

3

Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.

Berger K, Ehlken B, Kugland B, Augustin M. Berger K, et al. Among authors: ehlken b. J Dtsch Dermatol Ges. 2005 Jul;3(7):511-8. doi: 10.1111/j.1610-0387.2005.05729.x. J Dtsch Dermatol Ges. 2005. PMID: 15967010

4

[Cost-of-illness study in patients suffering from atopic eczema in Germany].

Ehlken B, Möhrenschlager M, Kugland B, Berger K, Quednau K, Ring J. Ehlken B, et al. Hautarzt. 2005 Dec;56(12):1144-51. doi: 10.1007/s00105-005-0953-2. Hautarzt. 2005. PMID: 15933866 German.

5

Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis.

Wollenberg A, Sidhu MK, Odeyemi I, Dorsch B, Koehne-Volland R, Schaff M, Ehlken B, Berger K. Wollenberg A, et al. Among authors: ehlken b. Br J Dermatol. 2008 Dec;159(6):1322-30. doi: 10.1111/j.1365-2133.2008.08807.x. Epub 2008 Sep 6. Br J Dermatol. 2008. PMID: 18782316 Clinical Trial.

6

Burden of pulmonary arterial hypertension in Germany.

Wilkens H, Grimminger F, Hoeper M, Stähler G, Ehlken B, Plesnila-Frank C, Berger K, Resch A, Ghofrani A. Wilkens H, et al. Among authors: ehlken b. Respir Med. 2010 Jun;104(6):902-10. doi: 10.1016/j.rmed.2010.01.002. Epub 2010 Feb 9. Respir Med. 2010. PMID: 20149617 Free article.

7

Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany.

Wefer B, Ehlken B, Bremer J, Burgdörfer H, Domurath B, Hampel C, Kutzenberger J, Seif C, Sievert KD, Berger K, Pannek J. Wefer B, et al. Among authors: ehlken b. World J Urol. 2010 Jun;28(3):385-90. doi: 10.1007/s00345-009-0466-1. Epub 2009 Aug 20. World J Urol. 2010. PMID: 19693509

8

Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study.

Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Schramm B, et al. Among authors: ehlken b. Eur Respir J. 2003 Jan;21(1):116-22. doi: 10.1183/09031936.03.00019502. Eur Respir J. 2003. PMID: 12570119 Free article.

9

Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in Austria.

Frühwirth M, Berger K, Ehlken B, Moll-Schüler I, Brösl S, Mutz I. Frühwirth M, et al. Among authors: ehlken b. Pediatr Infect Dis J. 2001 Feb;20(2):184-8. doi: 10.1097/00006454-200102000-00013. Pediatr Infect Dis J. 2001. PMID: 11224839

10

[Roflumilast in combination with long-acting bronchodilators in the management of patients with severe and very severe COPD. A cost-effectiveness analysis for Germany].

Nowak D, Ehlken B, Kotchie R, Wecht S, Magnussen H. Nowak D, et al. Among authors: ehlken b. Dtsch Med Wochenschr. 2013 Jan;138(4):119-25. doi: 10.1055/s-0032-1327416. Epub 2013 Jan 15. Dtsch Med Wochenschr. 2013. PMID: 23322425 Clinical Trial. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters